Ani John

745 total citations
30 papers, 575 citations indexed

About

Ani John is a scholar working on Rheumatology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ani John has authored 30 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 7 papers in Genetics and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ani John's work include Rheumatoid Arthritis Research and Therapies (19 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Ani John is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Systemic Lupus Erythematosus Research (7 papers). Ani John collaborates with scholars based in United States, Switzerland and Australia. Ani John's co-authors include Jeffrey R. Curtis, Marc C. Hochberg, Stephen S. Johnston, Nianwen Shi, Yusuf Yazıcı, Joel M. Kremer, George Reed, Jeffrey D. Greenberg, Leslie R. Harrold and David A. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Annals of the Rheumatic Diseases.

In The Last Decade

Ani John

29 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ani John United States	14	416	166	107	103	70	30	575
Kumi Shidara Japan	16	430 1.0×	126 0.8×	86 0.8×	99 1.0×	113 1.6×	30	586
Gülşen Özen Türkiye	13	372 0.9×	86 0.5×	98 0.9×	65 0.6×	81 1.2×	31	590
Darcy S. Majka United States	10	463 1.1×	94 0.6×	126 1.2×	37 0.4×	49 0.7×	15	647
Anne‐Barbara Mongey United States	12	274 0.7×	65 0.4×	92 0.9×	67 0.7×	58 0.8×	21	455
J.M. Kremer United States	10	551 1.3×	269 1.6×	194 1.8×	169 1.6×	77 1.1×	27	798
Maria D. Mjaavatten Norway	13	292 0.7×	84 0.5×	44 0.4×	52 0.5×	42 0.6×	28	389
Smolen Js Austria	11	458 1.1×	165 1.0×	183 1.7×	43 0.4×	101 1.4×	30	654
Alex Limanni United States	8	165 0.4×	107 0.6×	76 0.7×	33 0.3×	44 0.6×	13	364
Anders Gülfe Sweden	13	829 2.0×	283 1.7×	387 3.6×	116 1.1×	103 1.5×	21	1.1k
P. B. J. de Sonnaville Netherlands	14	525 1.3×	195 1.2×	88 0.8×	123 1.2×	90 1.3×	18	599

Countries citing papers authored by Ani John

Since Specialization

Citations

This map shows the geographic impact of Ani John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ani John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ani John more than expected).

Fields of papers citing papers by Ani John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ani John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ani John. The network helps show where Ani John may publish in the future.

Co-authorship network of co-authors of Ani John

This figure shows the co-authorship network connecting the top 25 collaborators of Ani John. A scholar is included among the top collaborators of Ani John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ani John. Ani John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talha, Khawaja M., James L. Januzzi, Tong Meng, et al.. (2024). Use of Natriuretic Peptides and Echocardiography for Diagnosing Heart Failure. European Journal of Heart Failure. 26(3). 551–560. 4 indexed citations

Franchini, Fanny, Roma Shah, Marliese Alexander, et al.. (2024). Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database. JTO Clinical and Research Reports. 5(8). 100662–100662. 4 indexed citations

Curtis, Jeffrey R., Joel M. Kremer, George Reed, Ani John, & Dimitrios A. Pappas. (2021). TNFi Cycling Versus Changing Mechanism of Action in TNFi‐Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study. ACR Open Rheumatology. 4(1). 65–73. 10 indexed citations

John, Ani, Baiyu Yang, & Roma Shah. (2021). Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data. Advances in Therapy. 38(3). 1552–1566. 24 indexed citations

Shah, Roma, Ani John, & Marliese Alexander. (2019). P1.01-80 Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients. Journal of Thoracic Oncology. 14(10). S391–S391.

John, Ani, et al.. (2019). Value of precision medicine in advanced NSCLC: Real-world outcomes associated with the use of companion diagnostics.. Journal of Clinical Oncology. 37(15_suppl). e20015–e20015. 1 indexed citations

Harrold, Leslie R., Ani John, George Reed, et al.. (2017). Impact of Tocilizumab Monotherapy on Clinical and Patient-Reported Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis. Rheumatology and Therapy. 4(2). 405–417. 16 indexed citations

Harrold, Leslie R., Ani John, Jennie H. Best, et al.. (2017). Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry. Clinical Rheumatology. 36(9). 2135–2140. 11 indexed citations

Pappas, Dimitrios A., Ani John, Jeffrey R. Curtis, et al.. (2016). Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry. Rheumatology and Therapy. 3(1). 103–115. 8 indexed citations

10.

Soubrier, Martin, Jinglan Pei, Frédérick Durand, Lars Gullestad, & Ani John. (2016). Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis. Rheumatology and Therapy. 4(1). 133–149. 29 indexed citations

11.

Harrold, Leslie R., George Reed, Robert Magner, et al.. (2015). Comparative effectiveness and safety of rituximab versus subsequent anti–tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti–tumor necrosis factor therapies in the United States Corrona registry. Arthritis Research & Therapy. 17(1). 256–256. 44 indexed citations

12.

Pappas, Dimitrios A., George Reed, Katherine C. Saunders, et al.. (2015). Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population. Rheumatology and Therapy. 2(1). 85–96. 15 indexed citations

13.

Harrold, Leslie R., George Reed, J. Timothy Harrington, et al.. (2014). The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network. BMC Musculoskeletal Disorders. 15(1). 389–389. 10 indexed citations

14.

Pappas, Dimitrios A., Ani John, Joel M. Kremer, et al.. (2013). OP0005 Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases. 72. A49–A49. 2 indexed citations

15.

Curtis, Jeffrey R., Ani John, & Onur Başer. (2012). Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti–tumor necrosis factor therapy. Arthritis Care & Research. 64(9). 1282–1291. 40 indexed citations

16.

Curtis, Jeffrey R., Ángel Lanas, Ani John, David A. Johnson, & Kathy L. Schulman. (2012). Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care & Research. 64(12). 1819–1828. 58 indexed citations

17.

Curtis, Jeffrey R., Shih‐Yin Chen, Winifred Werther, Ani John, & David A. Johnson. (2011). Validation of ICD‐9‐CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients. Pharmacoepidemiology and Drug Safety. 20(11). 1150–1158. 18 indexed citations

18.

Yazıcı, Yusuf, Nianwen Shi, & Ani John. (2008). Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy.. PubMed. 66(2). 77–85. 79 indexed citations

19.

Hochberg, Marc C., Stephen S. Johnston, & Ani John. (2008). The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Current Medical Research and Opinion. 24(2). 469–480. 87 indexed citations

20.

Assmann, Gerd, Frank Kannenberg, Wayne Weng, et al.. (2004). 1008-183 Effects of ezetimibe, simvastatin, and ezetimibe-simvastatin on noncholesterol sterol. Journal of the American College of Cardiology. 43(5). A445–A446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact